Mansha Sachdev
June 24, 2021
Synthetic control arms (SCAs) leverage real world data from various sources or evaluations of historical clinical data..
Read article
Cytel
August 7, 2020
Recently a biotech approached Cytel for support with a Phase 2 Study in oncology. Regulators had requested a natural..
Read article
Kristian Thorlund
February 25, 2020
Over the past decade, a new trend began to emerge, changing the way that clinical trials are conducted. Whereas..
Read article
Kristian Thorlund
February 25, 2020
Regulators in both the United States and Europe have responded positively to the use of SCAs in clinical..
Read article
Cytel
December 10, 2019
In association with Statisticians in the Pharmaceutical Industry (PSI) , UCB and Cytel hosted a symposium on September..
Read article
